semaglutide dvt risk Carrying excess weight is a known factor for blood clots, but could GLP-1 medications like Ozempic, Wegovy, and Mounjaro help lower that risk? New research suggests they might. Join us for Frontiers | Tirzepatide and reduced

Cardiovascular outcomes data for Ozempic comes from the SELECT trial, which demonstrated a 20% reduction in major adverse cardiovascular events (heart attack, stroke, cardiovascular death) in patients with established heart disease but without diabetes

As access becomes more direct, -

A crossover study in Gastroenterology showed that meals exceeding 15 g of fat per sitting increased stool water content by 22% in subjects taking GLP-1 receptor agonists compared to low-fat meals 12

11.01.24 Warning label updated with new risk The FDA has updated the Ozempic label with an additional warning about an increased risk of pulmonary aspiration